Research

D Bolton, A Hong, N Papa, M Perera
Cribriform pattern disease over-represented in pelvic lymph node metastases identified on 68Ga PSMA-PET/CT
BJUI Compass. 2022, In press

This study aimed to determine if a specific histologic subtype of prostate cancer is preferentially represented in pelvic lymph node metastases detected using 68GA-PSMA-PET/CT.

A series of 66 men with biochemical recurrent prostate cancer underwent 68GA-PSMA-PET/CT. Twenty patients with disease confined to pelvic lymph nodes underwent salvage extended pelvic lymph node dissection. Researchers assessed lymph node positivity, histologic subtypes of the cancer, and PSA response to the intervention.

The mean PSA level at the time of PSMA scanning for these patients was 2.49. In 16 of the 20 patients, metastatic cribriform pattern prostate cancer was found in the excised nodes, with 11 of these 16 showing 100% cribriform pattern. Four patients did not have this histologic subtype. The PSA response was not related to the presence or amount of cribriform pattern disease.

The study concludes that cribriform pattern adenocarcinoma is the histologic subtype most commonly identified in pelvic lymph nodes on 68GA-PSMA-PET/CT. This imaging technique may be particularly useful for staging primary or recurrent prostate cancer in patients with cribriform pattern disease. Further research is needed to confirm this association.

Read the full article

Dr. Marlon Perera

Dr. Marlon Perera

Dr. Marlon Perera is an Australian-trained, award-winning urology surgeon who specialises in robotic surgery and uro-oncology. Dr. Perera has worldwide experience, having completed a PhD (Urology) and a prized-accredited ‘Society of Urologic Oncology’ (SUO) fellowship at one of the world’s best and most prestigious cancer centres – Memorial Sloan Kettering Cancer Center in New York City. He provides comprehensive care in the treatment of prostate cancer, kidney masses and cancers, bladder cancer, kidney stones, and voiding dysfunction.

Scroll to Top
Contact Us Call Now